» Articles » PMID: 21788632

Cluster-randomized Trial of a Mobile Phone Personalized Behavioral Intervention for Blood Glucose Control

Overview
Journal Diabetes Care
Specialty Endocrinology
Date 2011 Jul 27
PMID 21788632
Citations 313
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To test whether adding mobile application coaching and patient/provider web portals to community primary care compared with standard diabetes management would reduce glycated hemoglobin levels in patients with type 2 diabetes.

Research Design And Methods: A cluster-randomized clinical trial, the Mobile Diabetes Intervention Study, randomly assigned 26 primary care practices to one of three stepped treatment groups or a control group (usual care). A total of 163 patients were enrolled and included in analysis. The primary outcome was change in glycated hemoglobin levels over a 1-year treatment period. Secondary outcomes were changes in patient-reported diabetes symptoms, diabetes distress, depression, and other clinical (blood pressure) and laboratory (lipid) values. Maximal treatment was a mobile- and web-based self-management patient coaching system and provider decision support. Patients received automated, real-time educational and behavioral messaging in response to individually analyzed blood glucose values, diabetes medications, and lifestyle behaviors communicated by mobile phone. Providers received quarterly reports summarizing patient's glycemic control, diabetes medication management, lifestyle behaviors, and evidence-based treatment options.

Results: The mean declines in glycated hemoglobin were 1.9% in the maximal treatment group and 0.7% in the usual care group, a difference of 1.2% (P = 0.001) [corrected] over 12 months. Appreciable differences were not observed between groups for patient-reported diabetes distress, depression, diabetes symptoms, or blood pressure and lipid levels (all P > 0.05).

Conclusions: The combination of behavioral mobile coaching with blood glucose data, lifestyle behaviors, and patient self-management data individually analyzed and presented with evidence-based guidelines to providers substantially reduced glycated hemoglobin levels over 1 year.

Citing Articles

Technological functionality and system architecture of mobile health interventions for diabetes management: a systematic review and meta-analysis of randomized controlled trials.

Yu X, Wang Y, Liu Z, Jung E Front Public Health. 2025; 13:1549568.

PMID: 40051514 PMC: 11884075. DOI: 10.3389/fpubh.2025.1549568.


Assessing the Effectiveness of Digital Health Behavior Strategies on Type 2 Diabetes Management: Systematic Review and Network Meta-Analysis.

Li M, Liu S, Yu B, Li N, Lyu A, Yang H J Med Internet Res. 2025; 27:e63209.

PMID: 39951722 PMC: 11888087. DOI: 10.2196/63209.


e-Health applications for outpatient professional pharmaceutical care services: A scoping review.

Agudelo R, Pereanez J, Munoz S, Granados J, Ceballos M Explor Res Clin Soc Pharm. 2025; 17:100567.

PMID: 39926416 PMC: 11803173. DOI: 10.1016/j.rcsop.2025.100567.


Comorbidities And Reducing InEquitieS (CARES): Feasibility of self-monitoring and community health worker support in management of comorbidities among Black breast and prostate cancer patients.

Schubel L, Barac A, Magee M, Mete M, Peeples M, Shomali M Contemp Clin Trials Commun. 2025; 43():101387.

PMID: 39810843 PMC: 11732108. DOI: 10.1016/j.conctc.2024.101387.


Efficacy of a Multimodal Digital Behavior Change Intervention on Lifestyle Behavior, Cardiometabolic Biomarkers, and Medical Expenditure: Protocol for a Randomized Controlled Trial.

Howard-Wilson S, Ching J, Gentile S, Ho M, Garcia A, Ayturk D JMIR Res Protoc. 2024; 13:e50378.

PMID: 39475852 PMC: 11561444. DOI: 10.2196/50378.


References
1.
Saaddine J, Cadwell B, Gregg E, Engelgau M, Vinicor F, Imperatore G . Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002. Ann Intern Med. 2006; 144(7):465-74. DOI: 10.7326/0003-4819-144-7-200604040-00005. View

2.
Gerstein H, Miller M, Byington R, Goff Jr D, Thomas Bigger J, Buse J . Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008; 358(24):2545-59. PMC: 4551392. DOI: 10.1056/NEJMoa0802743. View

3.
Gaede P, Jepsen P, Larsen J, Jensen G, Parving H, Pedersen O . [The Steno-2 study. Intensive multifactorial intervention reduces the occurrence of cardiovascular disease in patients with type 2 diabetes]. Ugeskr Laeger. 2003; 165(26):2658-61. View

4.
. Standards of medical care in diabetes--2008. Diabetes Care. 2008; 31 Suppl 1:S12-54. DOI: 10.2337/dc08-S012. View

5.
Knowler W, Barrett-Connor E, Fowler S, Hamman R, Lachin J, Walker E . Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002; 346(6):393-403. PMC: 1370926. DOI: 10.1056/NEJMoa012512. View